↓ Skip to main content

Cochrane Database of Systematic Reviews

Risperidone versus other atypical antipsychotics for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, January 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
twitter
7 tweeters
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
89 Dimensions

Readers on

mendeley
234 Mendeley
connotea
1 Connotea
Title
Risperidone versus other atypical antipsychotics for schizophrenia
Published in
Cochrane database of systematic reviews, January 2011
DOI 10.1002/14651858.cd006626.pub2
Pubmed ID
Authors

Katja Komossa, Christine Rummel-Kluge, Sandra Schwarz, Franziska Schmid, Heike Hunger, Werner Kissling, Stefan Leucht

Abstract

In many countries of the industrialised world second-generation ("atypical") antipsychotics (SGAs) have become the first line drug treatment for people with schizophrenia. The question as to whether and if so how much the effects of the various SGAs differ is a matter of debate. In this review we examined how the efficacy and tolerability of risperidone differs from that of other SGAs.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 234 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 <1%
Uruguay 1 <1%
Chile 1 <1%
Brazil 1 <1%
United States 1 <1%
Unknown 228 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 43 18%
Researcher 35 15%
Student > Bachelor 25 11%
Student > Ph. D. Student 22 9%
Other 17 7%
Other 45 19%
Unknown 47 20%
Readers by discipline Count As %
Medicine and Dentistry 80 34%
Psychology 25 11%
Nursing and Health Professions 20 9%
Pharmacology, Toxicology and Pharmaceutical Science 15 6%
Neuroscience 8 3%
Other 30 13%
Unknown 56 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 September 2020.
All research outputs
#2,361,923
of 18,815,546 outputs
Outputs from Cochrane database of systematic reviews
#5,075
of 11,867 outputs
Outputs of similar age
#39,545
of 304,577 outputs
Outputs of similar age from Cochrane database of systematic reviews
#121
of 240 outputs
Altmetric has tracked 18,815,546 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,867 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.6. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 304,577 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 240 others from the same source and published within six weeks on either side of this one. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.